Nexalin Technology, Inc. Deferred Tax Assets, in Process Research and Development
Nexalin Technology, Inc. (NXL) had Deferred Tax Assets, in Process Research and Development of $376.00 thousand as of 2024-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment · last filed 2026-03-25
- 2024-12-31: Deferred Tax Assets, in Process Research and Development $376.00K.
- 2023-12-31: Deferred Tax Assets, in Process Research and Development $200.00K.
- 2022-12-31: Deferred Tax Assets, in Process Research and Development $97.00K.
| Period end | Deferred Tax Assets, in Process Research and Development |
|---|---|
| 2024-12-31 | $376.00K 10-K · filed 2026-03-25 |
| 2023-12-31 | $200.00K 10-K/A · filed 2025-09-23 |
| 2022-12-31 | $97.00K 10-K · filed 2024-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |